Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Abeona Therapeutics Inc. (ABEO)
USD7.00
-0.01 (-0.14%)
US NASDAQ Healthcare Biotechnology
Address
1330 Avenue of the Americas 10019
Cleveland, NY, US
Cleveland, NY, US
CEO
Vishwas Seshadri
Website
abeonatherapeutics.com
IPO
1980-09-19
CIK 318306 ISIN US00289Y2063
Also trades on
London Stock Exchange · 0H7R.L (USD)
NASDAQ Capital Market · ABEO (USD)
Description
Abeona Therapeutics Inc. is a biopharmaceutical company in the clinical development stage, focused on creating innovative gene and cell therapies to address severe and uncommon genetic diseases. Its leading program, EB-101, an autologous gene-corrected cell therapy, is presently in a Phase III clinical trial for treating recessive dystrophic epidermolysis bullosa. The company's pipeline also features several other promising therapies: ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A. ABO-201, intended for CLN3 disease. ABO-401, developed to treat cystic fibrosis. ABO-50X, aimed at various genetic eye disorders. Additionally, Abeona is advancing AAV-based gene therapy solutions through its proprietary AIM vector platform. The company, which was founded in 1974 and is headquartered in New York, New York, changed its name to Abeona Therapeutics Inc. in June 2015, having previously been known as PlasmaTech Biopharmaceuticals, Inc.
Market Cap & Enterprise Value
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD7.00
-0.01 (-0.14%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
1M
Beta
1.35
Float Shares
39.36M
Free Float %
69.0%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.07% | -2.24% | +12.25% | +13.37% | +25.39% | +7.78% | +0.89% | +84.42% | -82.39% | -90.33% | -100.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (9 ratings, all time)
Buy
Price Targets & DCF
Current price
7.00
Low
17.00
+142.9%
Consensus
17.00
+142.9%
Median
17.00
+142.9%
High
17.00
+142.9%
DCF (Unlevered)
0.80
-88.6%
DCF (Levered)
0.26
-96.3%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 6 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 1 |
17.00
+142.9%
|
| Last Year | 2 |
18.50
+164.3%
|
| All Time | 4 |
14.75
+110.7%
|
Quality scores
Altman Z-Score
-1.87
Distress
Piotroski F-Score
6 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
2 / 5
Medium
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
2 / 5
Medium
P/E Score
3 / 5
Medium
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%+165.2% ★ Q1'26: -25.0% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-1,695.5% Q1'26: -237.8% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-1,536.9% Q1'26: +0.0% (vs Q1'25)
-
ROIC Biotechnology: -16.1%— Q1'26: +0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+61.1% Q1'26: +13.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.29× Q1'26: -0.25× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2020 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 5 Rev. Ana. 4 EPS Ana. |
Dec 2027 5 Rev. Ana. 4 EPS Ana. |
Dec 2028 4 Rev. Ana. 4 EPS Ana. |
Dec 2029 3 Rev. Ana. 2 EPS Ana. |
Dec 2030 3 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.04M
est: 1.11M (-5.9%)
|
889.0K
est: 833.5K (+6.7%)
|
837.0K
est: 870.6K (-3.9%)
|
3.00M
est: 5.87M (-48.9%)
|
10.00M
est: 12.37M (-19.1%)
|
1.41M
est: 2.32M (-39.1%)
|
3.50M
est: 3.50M (+0.0%)
|
—
est: 100.0K (-100.0%)
|
5.82M
est: 4.82M (+20.6%)
|
64.15M
40.17M – 93.87M
+1,229.7% YoY
|
148.87M
99.51M – 192.08M
+132.1% YoY
|
245.06M
241.53M – 248.59M
+64.6% YoY
|
296.84M
194.99M – 400.36M
+21.1% YoY
|
356.62M
234.26M – 480.99M
+20.1% YoY
|
| EBITDA |
-13.97M
est: -663.0K (-2,006.9%)
|
-21.05M
est: -500.1K (-4,108.8%)
|
-26.58M
est: -522.3K (-4,988.2%)
|
-54.31M
est: -3.52M (-1,442.2%)
|
-74.52M
est: -7.42M (-904.3%)
|
-34.38M
est: -1.39M (-2,366.9%)
|
-50.57M
est: -2.10M (-2,308.2%)
|
-56.62M
est: -60.0K (-94,265.0%)
|
-85.89M
est: -2.89M (-2,867.0%)
|
-38.49M
-56.32M – -24.10M
-1,229.7% YoY
|
-89.32M
-115.25M – -59.71M
-132.1% YoY
|
-147.04M
-149.15M – -144.92M
-64.6% YoY
|
-178.10M
-240.22M – -116.99M
-21.1% YoY
|
-213.97M
-288.60M – -140.56M
-20.1% YoY
|
| EBIT |
-14.52M
est: -663.0K (-2,090.0%)
|
-21.87M
est: -500.1K (-4,273.7%)
|
-27.32M
est: -522.3K (-5,130.1%)
|
-56.67M
est: -3.52M (-1,509.2%)
|
-80.12M
est: -7.42M (-979.8%)
|
-38.96M
est: -1.39M (-2,695.2%)
|
-53.77M
est: -2.10M (-2,460.5%)
|
-59.53M
est: -60.0K (-99,110.0%)
|
-89.45M
est: -2.89M (-2,990.1%)
|
-38.49M
-56.32M – -24.10M
-1,229.7% YoY
|
-89.32M
-115.25M – -59.71M
-132.1% YoY
|
-147.04M
-149.15M – -144.92M
-64.6% YoY
|
-178.10M
-240.22M – -116.99M
-21.1% YoY
|
-213.97M
-288.60M – -140.56M
-20.1% YoY
|
| Net Income |
-14.53M
est: -492.58M (+97.1%)
|
-21.87M
est: -605.46M (+96.4%)
|
-27.32M
est: -623.03M (+95.6%)
|
-56.67M
est: -1.20B (+95.3%)
|
-84.23M
est: -844.90M (+90.0%)
|
-39.70M
est: -158.64M (+75.0%)
|
-54.19M
est: -113.23M (+52.1%)
|
-63.73M
est: -113.64M (+43.9%)
|
71.18M
est: 75.73M (-6.0%)
|
-43.17M
-76.26M – -28.09M
-157.0% YoY
|
9.41M
-23.31M – 31.25M
+121.8% YoY
|
74.89M
42.33M – 145.50M
+695.6% YoY
|
105.82M
58.62M – 153.79M
+41.3% YoY
|
136.02M
75.35M – 197.69M
+28.5% YoY
|
| SGA |
14.32M
est: 6.24M (+129.6%)
|
13.29M
est: 4.71M (+182.4%)
|
10.94M
est: 4.91M (+122.7%)
|
20.11M
est: 33.13M (-39.3%)
|
23.78M
est: 69.81M (-65.9%)
|
17.26M
est: 13.11M (+31.6%)
|
19.00M
est: 25.92M (-26.7%)
|
29.85M
est: 740.4K (+3,931.5%)
|
65.03M
est: 35.72M (+82.0%)
|
475.01M
297.46M – 695.01M
+1,229.7% YoY
|
1.10B
736.84M – 1.42B
+132.1% YoY
|
1.81B
1.79B – 1.84B
+64.6% YoY
|
2.20B
1.44B – 2.96B
+21.1% YoY
|
2.64B
1.73B – 3.56B
+20.1% YoY
|
| EPS |
-13.16
est: -12.00 (-9.7%)
|
-16.00
est: -14.75 (-8.5%)
|
-16.40
est: -15.18 (-8.1%)
|
-29.81
est: -29.31 (-1.7%)
|
-22.75
est: -20.58 (-10.5%)
|
-5.53
est: -3.92 (-41.3%)
|
-2.53
est: -1.78 (-41.8%)
|
-1.55
est: -1.72 (+10.1%)
|
1.34
est: 1.15 (+17.0%)
|
-0.74
-1.15 – -0.42
-164.5% YoY
|
0.14
-0.35 – 0.47
+118.3% YoY
|
1.14
0.64 – 2.20
+742.6% YoY
|
1.60
0.89 – 2.33
+40.7% YoY
|
2.06
1.14 – 2.99
+28.5% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | A- | 4/5 | 2/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-11 | A- | 4/5 | 2/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-08 | A- | 4/5 | 2/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-05-07 | A- | 4/5 | 2/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-05-06 | A- | 4/5 | 2/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-05-05 | A- | 4/5 | 2/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-05-04 | A- | 4/5 | 2/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-05-01 | A- | 4/5 | 2/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-30 | A- | 4/5 | 2/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-29 | A- | 4/5 | 2/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-28 | A- | 4/5 | 2/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-27 | A- | 4/5 | 2/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-24 | A | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-23 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-22 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-21 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-20 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-17 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-16 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-15 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-60.09M
OE per share TTM
-1.08
Owner's Yield
-19.98%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
431.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
1
Beneficial owners (>5%)
42
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Rouhandeh | 14.54M | 15.80% | 1.18M | 13.36M | 1.06M | 13.36M | IN | States | 2020-08-21 | ↗ |
| 2 | Capital Partners LLC | 12.00M | 14.10% | — | 12.00M | — | 12.00M | OO | Delaware | 2020-08-21 | ↗ |
| 3 | Dr. Jeffrey R. Jay, M.D. | 8.49M | 9.99% | — | 8.49M | — | — | HC, IN | Delaware | 2020-07-07 | ↗ |
| 4 | Mr. David Kroin | 8.49M | 9.99% | — | 8.49M | — | — | HC, IN | Delaware | 2020-07-07 | ↗ |
| 5 | Adage Capital Advisors, L.L.C. | 8.01M | 5.46% | — | 8.01M | — | — | OO | Delaware | 2022-02-10 | ↗ |
| 6 | Adage Capital Partners GP, L.L.C. | 8.01M | 5.46% | — | 8.01M | — | — | OO | Delaware | 2022-02-10 | ↗ |
| 7 | Adage Capital Partners, L.P. | 8.01M | 5.46% | — | 8.01M | — | — | PN | Delaware | 2022-02-10 | ↗ |
| 8 | Phillip Gross | 8.01M | 5.46% | — | 8.01M | — | — | IN | Delaware | 2022-02-10 | ↗ |
| 9 | Robert Atchinson | 8.01M | 5.46% | — | 8.01M | — | — | IN | Delaware | 2022-02-10 | ↗ |
| 10 | Aaron Cowen | 3.69M | 9.30% | — | 3.69M | — | 3.69M | HC, IN | Delaware | 2024-05-13 | ↗ |
| 11 | Suvretta Capital Management, LLC | 3.69M | 9.30% | — | 3.69M | — | 3.69M | IA, OO | Delaware | 2024-05-13 | ↗ |
| 12 | Averill Master Fund, Ltd. | 3.27M | 8.30% | — | 3.27M | — | 3.27M | CO | Delaware | 2024-05-13 | ↗ |
| 13 | 00-0000000 | 2.38M | 6.10% | — | 2.38M | — | 2.38M | CO | Jersey, Channel Islands | 2024-05-09 | ↗ |
| 14 | EIN #00-0000000 | 2.38M | 6.10% | — | 2.38M | — | 2.38M | IA, HC | Jersey, Channel Islands | 2024-05-09 | ↗ |
| 15 | EcoR1 Capital, LLC | 1.79M | 11.00% | — | 1.79M | — | 1.79M | IA, OO | United States | 2022-11-14 | ↗ |
| 16 | Oleg Nodelman | 1.79M | 11.00% | — | 1.79M | — | 1.79M | HC, IN | United States | 2022-11-14 | ↗ |
| 17 | Deerfield Management Company, L.P. | 1.74M | 5.06% | — | 1.74M | — | — | PN | Delaware | 2022-11-16 | ↗ |
| 18 | Deerfield Mgmt, L.P. | 1.74M | 5.06% | — | 1.74M | — | — | PN | Delaware | 2022-11-16 | ↗ |
| 19 | Deerfield Partners, L.P. | 1.74M | 5.06% | — | 1.74M | — | — | PN | Delaware | 2022-11-16 | ↗ |
| 20 | James E. Flynn | 1.74M | 5.06% | — | 1.74M | — | — | IN | Delaware | 2022-11-16 | ↗ |
| 21 | EcoR1 Capital Fund Qualified, L.P. | 1.72M | 11.00% | — | 1.72M | — | 1.72M | PN | United States | 2022-11-14 | ↗ |
| 22 | Capital LLC | 1.36M | 1.60% | — | 1.36M | — | 1.36M | OO | York | 2020-08-21 | ↗ |
| 23 | Israel A. Englander | 1.36M | 5.50% | — | 1.36M | — | 1.36M | IN | United States | 2023-12-04 | ↗ |
| 24 | Millennium Group Management LLC | 1.36M | 5.50% | — | 1.36M | — | 1.36M | OO | United States | 2023-12-04 | ↗ |
| 25 | Millennium Management LLC | 1.36M | 5.50% | — | 1.36M | — | 1.36M | OO | United States | 2023-12-04 | ↗ |
| 26 | Daniel Mack | 1.36M | 7.90% | — | 1.36M | — | — | HC | MA | 2023-02-14 | ↗ |
| 27 | Nantahala Capital Management, LLC | 1.36M | 7.90% | — | 1.36M | — | — | IA | MA | 2023-02-14 | ↗ |
| 28 | Wilmot B. Harkey | 1.36M | 7.90% | — | 1.36M | — | — | HC | MA | 2023-02-14 | ↗ |
| 29 | Integrated Core Strategies (US) LLC | 1.33M | 5.40% | — | 1.33M | — | 1.33M | OO | United States | 2023-12-04 | ↗ |
| 30 | Armistice Capital, LLC | 1.11M | 6.44% | — | 1.11M | — | — | IA, OO | Delaware | 2023-02-14 | ↗ |
| 31 | Steven Boyd | 1.11M | 6.44% | — | 1.11M | — | — | HC, IN | United States of America | 2023-02-14 | ↗ |
| 32 | Wellington Management Group LLP | 967.7K | 0.98% | — | 967.7K | — | 967.7K | HC | Massachusetts | 2021-02-03 | ↗ |
| 33 | Point72 Asset Management, L.P. | 888.9K | 4.00% | — | 888.9K | — | 960.9K | PN | United States | 2022-11-10 | ↗ |
| 34 | Point72 Capital Advisors, Inc. | 888.9K | 4.00% | — | 888.9K | — | 960.9K | CO | United States | 2022-11-10 | ↗ |
| 35 | Steven A. Cohen | 888.9K | 4.00% | — | 888.9K | — | 960.9K | IN | United States | 2022-11-10 | ↗ |
| 36 | 27-4413262 | 791.8K | 6.10% | 791.8K | — | 791.8K | — | OO | United States | 2022-11-04 | ↗ |
| 37 | Identification Nos. of above persons (. | 791.8K | 6.10% | 791.8K | — | 791.8K | — | IN | United States | 2022-11-04 | ↗ |
| 38 | Millennium International Management LP | 537.5K | 0.60% | — | 537.5K | — | 537.5K | PN | — | 2020-02-06 | ↗ |
| 39 | 52-0556948 | 2.1K | 0.00% | 2.1K | — | 2.1K | — | IA | Maryland | 2020-02-14 | ↗ |
| 40 | CVI Investments, Inc. | — | 0.00% | — | — | — | — | CO | — | 2021-02-16 | ↗ |
| 41 | Great Point Partners, LLC | — | 0.00% | — | — | — | — | IA, OO | USA | 2021-02-16 | ↗ |
| 42 | Heights Capital Management, Inc. | — | 0.00% | — | — | — | — | CO | — | 2021-02-16 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
1.00
Neutral
Ratio by volume
3.00
Bullish
Buys
1
Sells
1
Shares acquired
32.8K
Shares disposed
5.5K
Cash buys
—
Cash sales
1.00
Net activity
+27,203
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | Vasanthavada Madhav | Officer | S-Sale | D | Common Stock | 5,548 | 5.96 | 33.1K | 313,071 | D | ↗ |
| 2026-04-01 | Goldan Keith A. | Director | A-Award | A | Common Stock | 32,751 | 0.00 | — | 32,751 | D | ↗ |
| 2026-03-31 | Seshadri Vishwas | Director / Officer | S-Sale | D | Common Stock | 29,985 | 4.38 | 131.5K | 1,430,423 | D | ↗ |
| 2026-03-16 | Vazzano Joseph Walter | Officer | S-Sale | D | Common Stock | 785 | 4.76 | 3.7K | 567,775 | D | ↗ |
| 2026-02-02 | Wuchterl Donald A. | Director | S-Sale | D | Common Stock | 14,814 | 5.09 | 75.4K | 167,935 | D | ↗ |
| 2026-02-02 | Silverstein Christine Berni | Director | S-Sale | D | Common Stock | 20,070 | 5.09 | 102.2K | 137,722 | D | ↗ |
| 2026-02-02 | Crombez Eric | Director | S-Sale | D | Common Stock | 16,284 | 5.09 | 82.9K | 63,456 | D | ↗ |
| 2026-02-02 | Alvino Mark | Director | S-Sale | D | Common Stock | 2,000 | 5.09 | 10.2K | 84,065 | D | ↗ |
| 2026-02-02 | Alland Leila | Director | S-Sale | D | Common Stock | 18,065 | 5.09 | 92.0K | 173,614 | D | ↗ |
| 2026-01-26 | Zeiher Bernhardt G | Director | A-Award | A | Common Stock | 37,313 | 0.00 | — | 84,458 | D | ↗ |
| 2026-01-26 | Wuchterl Donald A. | Director | A-Award | A | Common Stock | 37,313 | 0.00 | — | 182,749 | D | ↗ |
| 2026-01-26 | Silverstein Christine Berni | Director | A-Award | A | Common Stock | 37,313 | 0.00 | — | 157,792 | D | ↗ |
| 2026-01-26 | Crombez Eric | Director | A-Award | A | Common Stock | 37,313 | 0.00 | — | 79,740 | D | ↗ |
| 2026-01-26 | Charles Faith L. | Director | A-Award | A | Common Stock | 37,313 | 0.00 | — | 176,407 | D | ↗ |
| 2026-01-26 | Amoroso Michael | Director | A-Award | A | Common Stock | 37,313 | 0.00 | — | 217,779 | D | ↗ |
| 2026-01-26 | Alvino Mark | Director | A-Award | A | Common Stock | 37,313 | 0.00 | — | 86,065 | D | ↗ |
| 2026-01-26 | Alland Leila | Director | A-Award | A | Common Stock | 37,313 | 0.00 | — | 191,679 | D | ↗ |
| 2026-01-22 | Vazzano Joseph Walter | Officer | S-Sale | D | Common Stock | 18,666 | 5.33 | 99.5K | 568,560 | D | ↗ |
| 2026-01-22 | Vasanthavada Madhav | Officer | S-Sale | D | Common Stock | 12,610 | 5.29 | 66.7K | 318,619 | D | ↗ |
| 2026-01-22 | Seshadri Vishwas | Director / Officer | S-Sale | D | Common Stock | 69,832 | 5.33 | 372.3K | 1,460,408 | D | ↗ |
| 2026-01-22 | O'Malley Brendan M. | Officer | S-Sale | D | Common Stock | 13,578 | 5.33 | 72.4K | 451,134 | D | ↗ |
| 2026-01-21 | Alvino Mark | Director | S-Sale | D | Common Stock | 13,500 | 5.23 | 70.6K | 48,752 | D | ↗ |
| 2026-01-20 | Vazzano Joseph Walter | Officer | A-Award | A | Common Stock | 133,595 | 0.00 | — | 587,226 | D | ↗ |
| 2026-01-20 | Vasanthavada Madhav | Officer | A-Award | A | Common Stock | 76,621 | 0.00 | — | 331,229 | D | ↗ |
| 2026-01-20 | Seshadri Vishwas | Director / Officer | A-Award | A | Common Stock | 365,422 | 0.00 | — | 1,530,240 | D | ↗ |
| 2026-01-20 | O'Malley Brendan M. | Officer | A-Award | A | Common Stock | 113,949 | 0.00 | — | 464,712 | D | ↗ |
| 2026-01-01 | Vasanthavada Madhav | Officer | — | — | Employee Stock Option (right to buy) | 2,400 | 4.00 | 9.6K | 0 | D | ↗ |
| 2025-12-29 | Seshadri Vishwas | Director / Officer | S-Sale | D | Common Stock | 25,000 | 5.31 | 132.7K | 1,164,818 | D | ↗ |
| 2025-11-13 | Alvino Mark | Director | S-Sale | D | Common Stock | 15,000 | 4.74 | 71.2K | 62,252 | D | ↗ |
| 2025-10-16 | Seshadri Vishwas | Director / Officer | S-Sale | D | Common Stock | 249 | 5.49 | 1.4K | 1,189,818 | D | ↗ |
| 2025-09-30 | Seshadri Vishwas | Director / Officer | S-Sale | D | Common Stock | 25,000 | 5.24 | 130.9K | 1,190,067 | D | ↗ |
| 2025-09-29 | Vazzano Joseph Walter | Officer | S-Sale | D | Common Stock | 9,035 | 5.39 | 48.7K | 453,631 | D | ↗ |
| 2025-09-29 | Seshadri Vishwas | Director / Officer | S-Sale | D | Common Stock | 19,274 | 5.39 | 104.0K | 1,215,067 | D | ↗ |
| 2025-09-29 | O'Malley Brendan M. | Officer | S-Sale | D | Common Stock | 9,366 | 5.39 | 50.5K | 350,763 | D | ↗ |
| 2025-09-22 | O'Malley Brendan M. | Officer | S-Sale | D | Common Stock | 688 | 5.43 | 3.7K | 360,129 | D | ↗ |
| 2025-08-15 | Vazzano Joseph Walter | Officer | S-Sale | D | Common Stock | 15,000 | 7.36 | 110.4K | 462,666 | D | ↗ |
| 2025-08-14 | Crombez Eric | Director | S-Sale | D | Common Stock | 4,718 | 6.93 | 32.7K | 42,427 | D | ↗ |
| 2025-07-22 | Vazzano Joseph Walter | Officer | S-Sale | D | Common Stock | 1,502 | 6.64 | 10.0K | 477,666 | D | ↗ |
| 2025-07-09 | Vazzano Joseph Walter | Officer | S-Sale | D | Common Stock | 25,411 | 5.86 | 148.8K | 479,168 | D | ↗ |
| 2025-07-09 | Silverstein Christine Berni | Director | S-Sale | D | Common Stock | 13,093 | 5.86 | 76.7K | 120,479 | D | ↗ |
| 2025-07-09 | Seshadri Vishwas | Director / Officer | S-Sale | D | Common Stock | 69,420 | 5.86 | 406.5K | 1,234,341 | D | ↗ |
| 2025-07-09 | O'Malley Brendan M. | Officer | S-Sale | D | Common Stock | 17,428 | 5.86 | 102.1K | 360,817 | D | ↗ |
| 2025-07-09 | Charles Faith L. | Director | S-Sale | D | Common Stock | 10,738 | 5.86 | 62.9K | 139,094 | D | ↗ |
| 2025-07-09 | Alvino Mark | Director | S-Sale | D | Common Stock | 13,093 | 5.86 | 76.7K | 77,252 | D | ↗ |
| 2025-07-08 | Wuchterl Donald A. | Director | S-Sale | D | Common Stock | 5,176 | 5.82 | 30.1K | 145,436 | D | ↗ |
| 2025-06-06 | Vazzano Joseph Walter | Officer | S-Sale | D | Common Stock | 17,795 | 6.76 | 120.3K | 491,246 | D | ↗ |
| 2025-06-06 | Seshadri Vishwas | Director / Officer | S-Sale | D | Common Stock | 50,676 | 6.76 | 342.6K | 1,303,761 | D | ↗ |
| 2025-06-06 | O'Malley Brendan M. | Officer | S-Sale | D | Common Stock | 10,470 | 6.76 | 70.8K | 378,245 | D | ↗ |
| 2025-06-05 | Vazzano Joseph Walter | Officer | A-Award | A | Common Stock | 13,333 | 0.00 | — | 504,579 | D | ↗ |
| 2025-06-01 | Seshadri Vishwas | Director / Officer | F-InKind | D | Common Stock | 885 | 6.24 | 5.5K | 1,354,437 | D | ↗ |
| 2025-05-27 | Alvino Mark | Director | S-Sale | D | Common Stock | 2,000 | 6.38 | 12.8K | 90,435 | D | ↗ |
| 2025-05-16 | Alvino Mark | Director | S-Sale | D | Common Stock | 8,000 | 5.68 | 45.4K | 92,435 | D | ↗ |
| 2025-03-31 | Seshadri Vishwas | Director / Officer | S-Sale | D | Common Stock | 25,000 | 4.78 | 119.5K | 1,355,322 | D | ↗ |
| 2025-03-14 | Vazzano Joseph Walter | Officer | F-InKind | D | Common stock | 685 | 5.29 | 3.6K | 509,041 | D | ↗ |
| 2025-03-03 | O'Malley Brendan M. | Officer | F-InKind | D | Common Stock | 181 | 5.24 | 948.44 | 388,715 | D | ↗ |
| 2025-01-31 | Zeiher Bernhardt G | Director | A-Award | A | Common Stock | 36,101 | 0.00 | — | 47,145 | D | ↗ |
| 2025-01-31 | Wuchterl Donald A. | Director | A-Award | A | Common Stock | 36,101 | 0.00 | — | 150,612 | D | ↗ |
| 2025-01-31 | Silverstein Christine Berni | Director | A-Award | A | Common Stock | 36,101 | 0.00 | — | 133,572 | D | ↗ |
| 2025-01-31 | Crombez Eric | Director | A-Award | A | Common Stock | 36,101 | 0.00 | — | 47,145 | D | ↗ |
| 2025-01-31 | Charles Faith L. | Director | A-Award | A | Common Stock | 36,101 | 0.00 | — | 149,832 | D | ↗ |
| 2025-01-31 | Amoroso Michael | Director | A-Award | A | Common Stock | 36,101 | 0.00 | — | 180,466 | D | ↗ |
| 2025-01-31 | Alvino Mark | Director | A-Award | A | Common Stock | 36,101 | 0.00 | — | 100,435 | D | ↗ |
| 2025-01-31 | Alland Leila | Director | A-Award | A | Common Stock | 36,101 | 0.00 | — | 154,366 | D | ↗ |
| 2025-01-29 | Alvino Mark | Director | S-Sale | D | Common Stock | 4,000 | 5.38 | 21.5K | 64,334 | D | ↗ |
| 2025-01-21 | Vazzano Joseph Walter | Officer | A-Award | A | Common stock | 144,509 | 0.00 | — | 509,726 | D | ↗ |
| 2025-01-21 | Seshadri Vishwas | Director / Officer | A-Award | A | Common Stock | 476,435 | 0.00 | — | 1,380,322 | D | ↗ |
| 2025-01-21 | O'Malley Brendan M. | Officer | A-Award | A | Common Stock | 115,607 | 0.00 | — | 388,896 | D | ↗ |
| 2025-01-21 | Alvino Mark | Director | S-Sale | D | Common Stock | 4,000 | 5.10 | 20.4K | 68,334 | D | ↗ |
| 2024-10-16 | Seshadri Vishwas | Director / Officer | F-InKind | D | Common Stock | 251 | 6.54 | 1.6K | 903,887 | D | ↗ |
| 2024-09-28 | Vazzano Joseph Walter | Officer | F-InKind | D | Common stock | 6,388 | 5.89 | 37.6K | 365,217 | D | ↗ |
| 2024-09-28 | Seshadri Vishwas | Director / Officer | F-InKind | D | Common Stock | 18,798 | 5.89 | 110.7K | 904,138 | D | ↗ |
| 2024-09-28 | O'Malley Brendan M. | Officer | F-InKind | D | Common Stock | 6,579 | 5.89 | 38.8K | 273,289 | D | ↗ |
| 2024-09-20 | O'Malley Brendan M. | Officer | F-InKind | D | Common Stock | 496 | 6.02 | 3.0K | 279,868 | D | ↗ |
| 2024-08-26 | Wuchterl Donald A. | Director | A-Award | A | Common Stock | 11,797 | 0.00 | — | 114,511 | — | ↗ |
| 2024-08-26 | Silverstein Christine Berni | Director | A-Award | A | Common Stock | 11,797 | 0.00 | — | 97,471 | — | ↗ |
| 2024-08-26 | Charles Faith L. | Director | A-Award | A | Common Stock | 11,797 | 0.00 | — | 113,731 | — | ↗ |
| 2024-08-26 | Amoroso Michael | Director | A-Award | A | Common Stock | 11,797 | 0.00 | — | 144,365 | — | ↗ |
| 2024-08-26 | Alvino Mark | Director | A-Award | A | Common Stock | 11,797 | 0.00 | — | 72,334 | — | ↗ |
| 2024-08-26 | Alland Leila | Director | A-Award | A | Common Stock | 11,797 | 0.00 | — | 118,265 | — | ↗ |
| 2024-08-13 | Zeiher Bernhardt G | Director | A-Award | A | Common Stock | 11,044 | 0.00 | — | 11,044 | — | ↗ |
| 2024-08-13 | Crombez Eric | Director | A-Award | A | Common Stock | 11,044 | 0.00 | — | 11,044 | — | ↗ |
| 2024-08-12 | Crombez Eric | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-08-08 | Zeiher Bernhardt G | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-07-21 | Vazzano Joseph Walter | Officer | F-InKind | D | Common stock | 1,055 | 5.11 | 5.4K | 371,605 | — | ↗ |
| 2024-07-08 | Wuchterl Donald A. | Director | A-Award | A | Common Stock | 23,611 | 0.00 | — | 102,714 | — | ↗ |
| 2024-07-08 | Vazzano Joseph Walter | Officer | A-Award | A | Common stock | 155,200 | 0.00 | — | 372,660 | — | ↗ |
| 2024-07-08 | Silverstein Christine Berni | Director | A-Award | A | Common Stock | 23,611 | 0.00 | — | 85,674 | — | ↗ |
| 2024-07-08 | Seshadri Vishwas | Director / Officer | A-Award | A | Common Stock | 424,000 | 0.00 | — | 922,936 | — | ↗ |
| 2024-07-08 | O'Malley Brendan M. | Officer | A-Award | A | Common stock | 102,689 | 0.00 | — | 280,364 | — | ↗ |
| 2024-07-08 | Charles Faith L. | Director | A-Award | A | Common Stock | 23,611 | 0.00 | — | 101,934 | — | ↗ |
| 2024-07-08 | Amoroso Michael | Director | A-Award | A | Common Stock | 23,611 | 0.00 | — | 132,568 | — | ↗ |
| 2024-07-08 | Alvino Mark | Director | A-Award | A | Common Stock | 23,611 | 0.00 | — | 60,537 | — | ↗ |
| 2024-07-08 | Alland Leila | Director | A-Award | A | Common Stock | 23,611 | 0.00 | — | 106,468 | — | ↗ |
| 2024-06-18 | Silverstein Christine Berni | Director | S-Sale | D | Common Stock | 25,821 | 4.51 | 116.5K | 62,063 | — | ↗ |
| 2024-06-18 | Alvino Mark | Director | S-Sale | D | Common Stock | 25,890 | 4.51 | 116.8K | 36,926 | — | ↗ |
| 2024-06-05 | Vazzano Joseph Walter | Officer | F-InKind | D | Common stock | 16,408 | 4.52 | 74.2K | 217,460 | — | ↗ |
| 2024-06-05 | Seshadri Vishwas | Director / Officer | F-InKind | D | Common Stock | 38,621 | 4.52 | 174.6K | 498,936 | — | ↗ |
| 2024-06-05 | O'Malley Brendan M. | Officer | F-InKind | D | Common stock | 10,951 | 4.52 | 49.5K | 177,675 | — | ↗ |
| 2024-06-03 | Seshadri Vishwas | Director / Officer | F-InKind | D | Common Stock | 703 | 4.38 | 3.1K | 537,557 | — | ↗ |
| 2024-05-16 | Alland Leila | Director | P-Purchase | A | Common Stock | 11,000 | 4.71 | 51.8K | 82,857 | — | ↗ |
| 2024-05-07 | Adage Capital Management, L.P. | 10% Owner | P-Purchase | A | Pre-funded Warrant (right to buy) | 2,948,475 | 0.00 | — | 2,948,475 | — | ↗ |
| 2024-04-26 | Charles Faith L. | Director | P-Purchase | A | Common Stock | 7,550 | 3.28 | 24.8K | 78,323 | — | ↗ |
| 2024-04-25 | Vazzano Joseph Walter | Officer | P-Purchase | A | Common stock | 5,608 | 3.14 | 17.6K | 233,868 | — | ↗ |
| 2024-04-25 | Seshadri Vishwas | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 3.20 | 32.0K | 538,260 | — | ↗ |
| 2024-04-25 | O'Malley Brendan M. | Officer | P-Purchase | A | Common stock | 8,600 | 3.24 | 27.9K | 188,718 | — | ↗ |
| 2024-03-31 | O'Malley Brendan M. | Officer | F-InKind | D | Common stock | 92 | 7.25 | 667.00 | 180,026 | — | ↗ |
| 2024-03-15 | Vazzano Joseph Walter | Officer | F-InKind | D | Common stock | 703 | 8.14 | 5.7K | 228,260 | — | ↗ |
| 2024-03-04 | O'Malley Brendan M. | Officer | F-InKind | D | Common stock | 183 | 7.81 | 1.4K | 180,118 | — | ↗ |
| 2024-02-06 | Seshadri Vishwas | Director / Officer | P-Purchase | A | Common Stock | 20,000 | 4.39 | 87.8K | 528,260 | — | ↗ |
| 2024-01-17 | Alvino Mark | Director | S-Sale | D | Common Stock | 7,084 | 5.11 | 36.2K | 62,816 | — | ↗ |
| 2023-10-16 | Seshadri Vishwas | Director / Officer | F-InKind | D | Common Stock | 181 | 4.14 | 749.34 | 508,260 | — | ↗ |
| 2023-09-29 | Vazzano Joseph Walter | Officer | F-InKind | D | Common stock | 6,230 | 3.93 | 24.5K | 228,963 | — | ↗ |
| 2023-09-29 | Seshadri Vishwas | Director / Officer | F-InKind | D | Common Stock | 13,290 | 3.93 | 52.2K | 508,441 | — | ↗ |
| 2023-09-29 | O'Malley Brendan M. | Officer | F-InKind | D | Common stock | 6,557 | 3.93 | 25.8K | 180,301 | — | ↗ |
| 2023-09-27 | Silverstein Christine Berni | Director | S-Sale | D | Common Stock | 6,330 | 3.91 | 24.7K | 87,884 | — | ↗ |
| 2023-09-27 | Seshadri Vishwas | Director / Officer | P-Purchase | A | Common Stock | 20,000 | 4.07 | 81.4K | 521,731 | — | ↗ |
| 2023-09-27 | Charles Faith L. | Director | S-Sale | D | Common Stock | 8,330 | 4.91 | 40.9K | 70,773 | — | ↗ |
| 2023-09-27 | Amoroso Michael | Director | S-Sale | D | Common Stock | 5,508 | 3.91 | 21.5K | 108,957 | — | ↗ |
| 2023-09-27 | Alvino Mark | Director | S-Sale | D | Common Stock | 6,316 | 3.91 | 24.7K | 69,900 | — | ↗ |
| 2023-09-27 | Alland Leila | Director | S-Sale | D | Common Stock | 7,246 | 3.90 | 28.3K | 71,857 | — | ↗ |
| 2023-09-21 | O'Malley Brendan M. | Officer | F-InKind | D | Common stock | 563 | 3.80 | 2.1K | 186,858 | — | ↗ |
| 2023-09-20 | Amoroso Michael | Director | S-Sale | D | Common Stock | 327 | 3.90 | 1.3K | 114,465 | — | ↗ |
| 2023-09-19 | Vazzano Joseph Walter | Officer | P-Purchase | A | Common stock | 2,986 | 3.82 | 11.4K | 238,179 | — | ↗ |
| 2023-09-18 | O'Malley Brendan M. | Officer | P-Purchase | A | Common stock | 3,000 | 3.80 | 11.4K | 187,421 | — | ↗ |
| 2023-07-24 | Vazzano Joseph Walter | Officer | F-InKind | D | Common stock | 1,187 | 3.73 | 4.4K | 235,179 | — | ↗ |
| 2023-07-03 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 10% Owner | — | I | Common Stock, $0.01 par value ("Common Stock") | 0 | 0.00 | — | 3,249,994 | — | ↗ |
| 2023-06-20 | Amoroso Michael | Director | S-Sale | D | Common Stock | 338 | 4.45 | 1.5K | 114,792 | — | ↗ |
| 2023-06-14 | Wuchterl Donald A. | Director | A-Award | A | Common Stock | 58,689 | 4.62 | 271.1K | 79,103 | — | ↗ |
| 2023-06-14 | Silverstein Christine Berni | Director | A-Award | A | Common Stock | 58,689 | 4.62 | 271.1K | 94,214 | — | ↗ |
| 2023-06-14 | Charles Faith L. | Director | A-Award | A | Common Stock | 58,689 | 4.62 | 271.1K | 79,103 | — | ↗ |
| 2023-06-14 | Amoroso Michael | Director | A-Award | A | Common Stock | 58,689 | 4.62 | 271.1K | 115,130 | — | ↗ |
| 2023-06-14 | Alvino Mark | Director | A-Award | A | Common Stock | 58,689 | 4.62 | 271.1K | 76,216 | — | ↗ |
| 2023-06-14 | Alland Leila | Director | A-Award | A | Common Stock | 58,689 | 4.62 | 271.1K | 79,103 | — | ↗ |
| 2023-06-05 | Vazzano Joseph Walter | Officer | A-Award | A | Common stock | 141,908 | 0.00 | — | 236,366 | — | ↗ |
| 2023-06-05 | Seshadri Vishwas | Director / Officer | A-Award | A | Common Stock | 336,826 | 0.00 | — | 501,731 | — | ↗ |
| 2023-06-05 | O'Malley Brendan M. | Officer | A-Award | A | Common stock | 90,902 | 0.00 | — | 184,421 | — | ↗ |
| 2023-06-02 | Seshadri Vishwas | Director / Officer | F-InKind | D | Common Stock | 827 | 3.06 | 2.5K | 164,905 | — | ↗ |
| 2023-04-25 | Alvino Mark | Director | S-Sale | D | Common Stock | 887 | 3.25 | 2.9K | 17,527 | — | ↗ |
| 2023-04-03 | O'Malley Brendan M. | Officer | F-InKind | D | Common stock | 104 | 2.82 | 293.28 | 93,519 | — | ↗ |
| 2023-03-20 | Amoroso Michael | Director | S-Sale | D | Common Stock | 268 | 2.33 | 624.44 | 56,441 | — | ↗ |
| 2023-03-15 | Vazzano Joseph Walter | Officer | F-InKind | D | Common stock | 792 | 2.60 | 2.1K | 94,458 | — | ↗ |
| 2023-03-03 | O'Malley Brendan M. | Officer | F-InKind | D | Common stock | 207 | 2.28 | 471.96 | 93,623 | — | ↗ |
| 2023-03-03 | Amoroso Michael | Director | S-Sale | D | Common Stock | 1,002 | 2.38 | 2.4K | 56,709 | — | ↗ |
| 2022-12-09 | O'Malley Brendan M. | Officer | P-Purchase | A | Common stock | 5,869 | 3.13 | 18.4K | 93,830 | — | ↗ |
| 2022-11-18 | Vazzano Joseph Walter | Officer | P-Purchase | A | Common stock | 2,500 | 4.00 | 10.0K | 95,250 | — | ↗ |
| 2022-11-18 | O'Malley Brendan M. | Officer | P-Purchase | A | Common stock | 7,500 | 3.99 | 29.9K | 87,961 | — | ↗ |
| 2022-11-07 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 10% Owner | — | I | Warrants (right to buy) | 760,870 | 4.75 | 3.61M | 0 | — | ↗ |
| 2022-10-17 | Seshadri Vishwas | Officer | F-InKind | D | Common Stock | 207 | 4.30 | 890.10 | 165,732 | — | ↗ |
| 2022-09-28 | Vazzano Joseph Walter | Officer | A-Award | A | Common stock | 72,750 | 0.00 | — | 92,750 | — | ↗ |
| 2022-09-28 | Seshadri Vishwas | Officer | A-Award | A | Common Stock | 155,200 | 0.00 | — | 165,939 | — | ↗ |
| 2022-09-28 | O'Malley Brendan M. | Officer | A-Award | A | Common stock | 72,750 | 0.00 | — | 80,461 | — | ↗ |
| 2022-09-26 | Mann Paul Elliot | Director | A-Award | A | Common Stock | 13,400 | 0.00 | — | 16,907 | — | ↗ |
| 2022-09-26 | Amoroso Michael | Director | A-Award | A | Common Stock | 13,400 | 0.00 | — | 57,711 | — | ↗ |
| 2022-07-21 | Vazzano Joseph Walter | Officer | A-Award | A | Common stock | 12,000 | 0.00 | — | 20,000 | — | ↗ |
| 2022-06-15 | Alvino Mark | Director | S-Sale | D | Common Stock | 20,000 | 0.15 | 3.1K | 27,181 | — | ↗ |
| 2022-06-06 | Alvino Mark | Director | S-Sale | D | Common Stock | 35,000 | 0.16 | 5.5K | 47,181 | — | ↗ |
| 2022-06-01 | Seshadri Vishwas | Officer | F-InKind | D | Common Stock | 81,525 | 0.16 | 13.0K | 268,475 | — | ↗ |
| 2022-03-14 | Vazzano Joseph Walter | Officer | — | D | Common stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-06 | O'Malley Brendan M. | Officer | S-Sale | D | Common stock | 8,880 | 0.57 | 5.0K | 204,750 | — | ↗ |
| 2021-11-05 | O'Malley Brendan M. | Officer | S-Sale | D | Common stock | 8,880 | 0.89 | 7.9K | 213,630 | — | ↗ |
| 2021-10-15 | Seshadri Vishwas | Director / Officer | A-Award | A | Common stock | 50,000 | 0.00 | — | 350,000 | — | ↗ |
| 2021-10-11 | O'Malley Brendan M. | Officer | S-Sale | D | Common stock | 25,734 | 0.90 | 23.3K | 222,510 | — | ↗ |
| 2021-10-08 | O'Malley Brendan M. | Officer | S-Sale | D | Common stock | 22,763 | 1.05 | 23.9K | 248,244 | — | ↗ |
| 2021-10-08 | CARR EDWARD | Officer | S-Sale | D | Common stock | 29,122 | 1.05 | 30.6K | 400,169 | — | ↗ |
| 2021-10-07 | Wider Todd | Director | S-Sale | D | Common Stock | 25,000 | 0.97 | 24.2K | 0 | — | ↗ |
| 2021-10-05 | O'Malley Brendan M. | Officer | S-Sale | D | Common stock | 2,447 | 1.05 | 2.6K | 271,007 | — | ↗ |
| 2021-09-30 | Amoroso Michael | Director / Officer | S-Sale | D | Common stock | 45,409 | 1.09 | 49.4K | 604,637 | — | ↗ |
| 2021-09-20 | O'Malley Brendan M. | Officer | — | D | Common stock | 0 | 0.00 | — | 137,454 | — | ↗ |
| 2021-08-10 | CARR EDWARD | Officer | A-Award | A | Stock Option (right to buy) | 476,000 | 1.26 | 599.8K | 476,000 | — | ↗ |
| 2021-06-01 | Seshadri Vishwas | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-05-25 | Wuchterl Donald A. | Director | A-Award | A | Common Stock | 77,181 | 0.00 | — | 77,181 | — | ↗ |
| 2021-05-25 | Wider Todd | Director | A-Award | A | Stock Option (right to buy) | 49,084 | 1.49 | 73.1K | 49,084 | — | ↗ |
| 2021-05-25 | Silverstein Christine Berni | Director | A-Award | A | Stock Option (right to buy) | 49,084 | 1.49 | 73.1K | 49,084 | — | ↗ |
| 2021-05-25 | Rouhandeh Steven H | Director / 10% Owner | A-Award | A | Stock Option (right to buy) | 49,084 | 1.49 | 73.1K | 49,084 | — | ↗ |
| 2021-05-25 | Mann Paul Elliot | Director | A-Award | A | Common Stock | 38,590 | 0.00 | — | 38,590 | — | ↗ |
| 2021-05-25 | Charles Faith L. | Director | A-Award | A | Common Stock | 77,181 | 0.00 | — | 77,181 | — | ↗ |
| 2021-05-25 | Alvino Mark | Director | A-Award | A | Common Stock | 77,181 | 0.00 | — | 82,181 | — | ↗ |
| 2021-05-25 | Alland Leila | Director | A-Award | A | Stock Option (right to buy) | 98,168 | 1.49 | 146.3K | 98,168 | — | ↗ |
| 2021-05-03 | SCO CAPITAL PARTNERS LLC | Director / 10% Owner | S-Sale | D | Common Stock | 80,000 | 2.01 | 160.9K | 11,079,292 | — | ↗ |
| 2021-04-14 | Wuchterl Donald A. | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-04-14 | Alland Leila | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-04-05 | CARR EDWARD | Officer | S-Sale | D | Common stock | 35,000 | 1.80 | 62.8K | 191,291 | — | ↗ |
| 2021-04-01 | CARR EDWARD | Officer | S-Sale | D | Common stock | 20,445 | 1.85 | 37.9K | 226,291 | — | ↗ |
| 2021-03-31 | Amoroso Michael | Director / Officer | S-Sale | D | Common stock | 45,409 | 1.87 | 84.9K | 650,046 | — | ↗ |
| 2021-03-26 | Charles Faith L. | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-03-26 | Alvino Mark | Director | — | D | Common stock | 0 | 0.00 | — | 5,000 | — | ↗ |
| 2021-03-19 | Amoroso Michael | Director / Officer | A-Award | A | Common stock | 250,000 | 0.00 | — | 695,455 | — | ↗ |
| 2021-03-18 | SCO CAPITAL PARTNERS LLC | Director / 10% Owner | S-Sale | D | Common Stock | 80,000 | 2.23 | 178.6K | 11,159,292 | — | ↗ |
| 2021-03-01 | CARR EDWARD | Officer | A-Award | A | Common stock | 50,000 | 0.00 | — | 246,736 | — | ↗ |
| 2021-03-01 | Amoroso Michael | Officer | A-Award | A | Common stock | 200,000 | 0.00 | — | 445,455 | — | ↗ |
| 2021-02-19 | Wider Todd | Director | S-Sale | D | Common Stock | 251,625 | 2.39 | 601.1K | 25,000 | — | ↗ |
| 2021-02-19 | Mann Paul Elliot | Director | M-Exempt | D | Stock Option (Right to Buy) | 45,566 | 1.28 | 58.3K | 0 | — | ↗ |
| 2021-02-18 | Wider Todd | Director | M-Exempt | D | Stock Option (Right to Buy) | 1,345 | 1.28 | 1.7K | 0 | — | ↗ |
| 2021-02-17 | Wider Todd | Director | M-Exempt | A | Common Stock | 50,000 | 1.28 | 64.0K | 426,625 | — | ↗ |
| 2021-02-17 | Mann Paul Elliot | Director | S-Sale | D | Common Stock | 132,664 | 2.34 | 310.2K | 0 | — | ↗ |
| 2021-02-16 | SCO CAPITAL PARTNERS LLC | Director / 10% Owner | S-Sale | D | Common Stock | 120,000 | 2.97 | 356.8K | 11,239,292 | — | ↗ |
| 2021-02-08 | SCO CAPITAL PARTNERS LLC | Director / 10% Owner | S-Sale | D | Common Stock | 240,000 | 3.01 | 722.8K | 11,359,292 | — | ↗ |
| 2021-01-19 | SCO CAPITAL PARTNERS LLC | Director / 10% Owner | S-Sale | D | Common Stock | 207,117 | 2.08 | 431.2K | 11,599,292 | — | ↗ |
| 2021-01-15 | SCO CAPITAL PARTNERS LLC | Director / 10% Owner | S-Sale | D | Common Stock | 81,283 | 2.02 | 164.1K | 11,806,409 | — | ↗ |
| 2021-01-14 | SCO CAPITAL PARTNERS LLC | Director / 10% Owner | S-Sale | D | Common Stock | 31,600 | 2.00 | 63.2K | 11,887,692 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-6.6K
Shares Outstanding
57.05M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Vishwas Seshadri President and Chief Executive Officer | 662.0K | 533.3K | 2.47M | — | 309.5K | 14.0K | 3.99M | 61.95% | ↗ |
| 2 | 2025 | Joseph Vazzano Chief Financial Officer | 475.9K | 235.3K | 836.4K | — | 173.2K | 14.0K | 1.73M | 48.21% | ↗ |
| 3 | 2025 | Brendan O’Malley Chief Legal Officer | 456.4K | 150.0K | 600.0K | — | 163.5K | 14.0K | 1.38M | 43.35% | ↗ |
| 4 | 2024 | Vishwas Seshadri President and Chief Executive Officer | 615.4K | 533.3K | 2.04M | — | 309.0K | 13.8K | 3.51M | 58.04% | ↗ |
| 5 | 2024 | Joseph Vazzano Chief Financial Officer | 456.9K | 235.3K | 745.0K | — | 183.0K | 13.8K | 1.63M | 45.59% | ↗ |
| 6 | 2024 | Brendan O’Malley General Counsel | 438.2K | 150.0K | 492.9K | — | 175.6K | 13.8K | 1.27M | 38.80% | ↗ |
| 7 | 2024 | Brendan O’Malley Chief Legal Officer | 438.2K | 150.0K | 492.9K | — | 175.6K | 13.8K | 1.27M | 38.80% | ↗ |
| 8 | 2023 | Vishwas Seshadri President and Chief Executive Officer | 555.0K | 533.3K | 1.36M | — | 388.5K | 13.2K | 2.85M | 47.67% | ↗ |
| 9 | 2023 | Joseph Vazzano Chief Financial Officer | 440.0K | 235.3K | 571.9K | — | 232.3K | 13.2K | 1.49M | 38.31% | ↗ |
| 10 | 2023 | Brendan O’Malley General Counsel | 422.0K | 150.0K | 366.3K | — | 217.8K | 13.2K | 1.17M | 31.33% | ↗ |
| 11 | 2022 | Vishwas Seshadri President and Chief Executive Officer | 505.0K | 125.3K | 478.0K | — | 378.8K | 12.8K | 1.50M | 31.87% | ↗ |
| 12 | 2022 | Joseph Vazzano Chief Financial Officer | 390.6K | 65.1K | 224.1K | — | 231.2K | 12.2K | 923.2K | 24.27% | ↗ |
| 13 | 2022 | Brendan O’Malley General Counsel | 390.6K | 65.1K | 224.1K | — | 231.2K | 12.2K | 923.2K | 24.27% | ↗ |
| 14 | 2022 | Edward Carr Former Chief Accounting Officer and Chief Financial Officer | 117.3K | — | — | — | — | 10.5K | 127.9K | 0.00% | ↗ |
| 15 | 2021 | Michael Amoroso Former President and Chief Executive Officer | 450.5K | — | 1.01M | 1.59M | — | 11.6K | 3.06M | 84.92% | ↗ |
| 16 | 2021 | Edward Carr Former Chief Accounting Officer and Chief Financial Officer | 361.0K | — | 416.9K | 634.2K | 146.2K | 11.6K | 1.57M | 66.95% | ↗ |
| 17 | 2021 | Vishwas Seshadri President and Chief Executive Officer | 254.6K | — | 558.5K | 744.6K | — | 8.9K | 1.57M | 83.18% | ↗ |
| 18 | 2021 | Brendan O’Malley General Counsel | 335.5K | — | 281.6K | 430.3K | 120.3K | 11.6K | 1.18M | 60.37% | ↗ |
| 19 | 2020 | Steven H. Rouhandeh Former Executive Chairman | 171.7K | 76.1K | 384.0K | 682.9K | — | 930.2K | 2.24M | 47.53% | ↗ |
| 20 | 2020 | Brian J.G. Pereira, M.D. Former Executive Chairman | 169.2K | — | — | 1.94M | — | — | 2.11M | 91.97% | ↗ |
| 21 | 2020 | Michael Amoroso President and Chief Executive Officer | 219.1K | 106.4K | 338.7K | 827.3K | — | 7.7K | 1.50M | 77.78% | ↗ |
| 22 | 2020 | Michael Amoroso Former President and Chief Executive Officer | 219.1K | 106.4K | 338.7K | 827.3K | — | 7.7K | 1.50M | 77.78% | ↗ |
| 23 | 2020 | Christine Silverstein Former Chief Financial Officer | 100.0K | 80.0K | 256.0K | 372.9K | — | 371.0K | 1.18M | 53.30% | ↗ |
| 24 | 2020 | João Siffert, M.D. Former Chief Executive Officer, Head of Research & Development and Chief Medical Officer | 426.0K | — | 320.0K | 348.0K | — | 11.4K | 1.11M | 60.43% | ↗ |
| 25 | 2020 | Edward Carr Chief Accounting Officer | 300.0K | 126.0K | 325.6K | 161.0K | — | 11.4K | 924.0K | 52.66% | ↗ |
| 26 | 2020 | Edward Carr Former Chief Accounting Officer and Chief Financial Officer | 300.0K | 126.0K | 325.6K | 161.0K | — | 11.4K | 924.0K | 52.66% | ↗ |
| 27 | 2019 | João Siffert, M.D. Chief Executive Officer, Head of Research & Development and Chief Medical Officer | 550.0K | 3.00 | — | 1.46M | — | 106.2K | 2.33M | 62.92% | ↗ |
| 28 | 2019 | João Siffert, M.D. Former Chief Executive Officer, Head of Research & Development and Chief Medical Officer | 550.0K | 206.3K | — | 1.46M | — | 106.2K | 2.33M | 62.92% | ↗ |
| 29 | 2019 | Steven H. Rouhandeh Executive Chairman | 571.7K | 3.00 | — | 682.8K | — | 11.2K | 1.48M | 46.13% | ↗ |
| 30 | 2019 | Steven H. Rouhandeh Former Executive Chairman | 571.7K | 214.4K | — | 682.8K | — | 11.2K | 1.48M | 46.13% | ↗ |
| 31 | 2019 | Christine Silverstein Chief Financial Officer | 350.0K | 3.00 | — | 566.2K | — | — | 1.00M | 56.61% | ↗ |
| 32 | 2019 | Christine Silverstein Former Chief Financial Officer | 350.0K | 84.0K | — | 566.2K | — | — | 1.00M | 56.61% | ↗ |
| 33 | 2018 | Frank Carsten Thiel, Ph.D. Former Chief Executive Officer | 358.6K | — | — | 3.77M | — | 41.5K | 4.17M | 90.41% | ↗ |
| 34 | 2018 | João Siffert, M.D. Chief Executive Officer, Head of Research & Development and Chief Medical Officer | 104.3K | 6.00 | — | 1.31M | — | 95.0K | 1.56M | 84.28% | ↗ |
| 35 | 2018 | Steven H. Rouhandeh Executive Chairman | 515.0K | 6.00 | — | — | — | 14.9K | 774.6K | 0.00% | ↗ |
| 36 | 2018 | Timothy J. Miller, Ph.D. President and Chief Scientific Officer | 433.8K | 124.9K | — | — | — | 17.3K | 576.0K | 0.00% | ↗ |
| 37 | 2017 | Steven H. Rouhandeh Executive Chairman | 386.0K | 154.0K | — | 1.52M | — | — | 2.06M | 73.80% | ↗ |
| 38 | 2017 | Timothy J. Miller, PhD President and Chief Executive Officer | 375.0K | 150.0K | — | 1.14M | — | — | 1.67M | 68.49% | ↗ |
| 39 | 2017 | Timothy J. Miller, Ph.D. President and Chief Scientific Officer | 375.0K | 150.0K | — | 1.14M | — | — | 1.67M | 68.49% | ↗ |
| 40 | 2017 | Jeffrey B. Davis Chief Operating Officer | 348.0K | 122.0K | — | 1.01M | — | — | 1.48M | 68.33% | ↗ |
| 41 | 2016 | Steven H. Rouhandeh Executive Chairman | 370.0K | 108.0K | — | 1.07M | — | — | 1.66M | 64.37% | ↗ |
| 42 | 2016 | Jeffrey B. Davis Chief Operating Officer | 334.0K | 165.0K | — | 799.0K | — | — | 1.40M | 57.11% | ↗ |
| 43 | 2016 | Timothy J. Miller, PhD President and Chief Executive Officer | 359.0K | 66.0K | — | 799.0K | — | — | 1.31M | 61.18% | ↗ |
| 44 | 2015 | Steven H. Rouhandeh Executive Chairman | 360.0K | — | 2.75M | 398.0K | — | — | 3.51M | 89.75% | ↗ |
| 45 | 2015 | Jeffrey B. Davis Chief Operating Officer | 325.0K | — | 2.20M | 495.0K | — | — | 3.02M | 89.25% | ↗ |
| 46 | 2015 | Jeffrey B. Davis Chief Operating Officer Former Chief Executive Officer | 325.0K | — | 2.20M | 495.0K | — | — | 3.02M | 89.25% | ↗ |
| 47 | 2015 | Harrison G. Wehner Chief Financial Officer | 350.0K | — | — | 351.0K | — | — | 701.0K | 50.07% | ↗ |
| 48 | 2015 | Timothy J. Miller, PhD President and Chief Executive Officer | 214.0K | — | — | 351.0K | — | — | 565.0K | 62.12% | ↗ |
| 49 | 2015 | Scott W. Schorer Former Chief Executive Officer | 123.0K | — | — | — | — | 100.0K | 223.0K | 0.00% | ↗ |
| 50 | 2014 | Jeffrey B. Davis Chief Operating Officer Former Chief Executive Officer | 290.0K | — | — | 262.0K | — | — | 552.0K | 47.46% | ↗ |
| 51 | 2014 | Steven H. Rouhandeh Executive Chairman | — | — | — | 523.0K | — | — | 523.0K | 100.00% | ↗ |
| 52 | 2014 | Scott W. Schorer Former Chief Executive Officer | 97.0K | — | — | — | — | — | 97.0K | 0.00% | ↗ |
| 53 | 2014 | Harrison G. Wehner President Chief Financial Officer | 97.0K | — | — | — | — | — | 97.0K | 0.00% | ↗ |
| 54 | 2014 | Harrison G. Wehner Chief Financial Officer | 97.0K | — | — | — | — | — | 97.0K | 0.00% | ↗ |
| 55 | 2014 | Scott W. Schorer Chief Executive Officer | 97.0K | — | — | — | — | — | 97.0K | 0.00% | ↗ |
| 56 | 2013 | Jeffrey B. Davis Chief Operating Officer Former Chief Executive Officer | 503.0K | — | — | — | — | — | 503.0K | 0.00% | ↗ |
| 57 | 2013 | Harrison G. Wehner President Chief Financial Officer | — | — | — | — | — | — | — | — | ↗ |
| 58 | 2013 | Scott W. Schorer Chief Executive Officer | — | — | — | — | — | — | — | — | ↗ |
| 59 | 2013 | Steven H. Rouhandeh Executive Chairman | — | — | — | — | — | — | — | — | ↗ |
| 60 | 2008 | David P. Nowotnik, Ph.D. Senior Vice President Research | 253.6K | — | — | — | — | 12.2K | 402.8K | 0.00% | ↗ |
| 61 | 2008 | Phillip S. Wise Vice President, Business | 200.0K | — | — | — | — | 9.9K | 346.9K | 0.00% | ↗ |
| 62 | 2008 | Stephen B. Thompson Vice President, Chief Financial Officer | 154.1K | — | — | — | — | 7.6K | 298.7K | 0.00% | ↗ |
| 63 | 2008 | Jeffrey B. Davis Chief Operating Officer Former Chief Executive Officer | 266.1K | — | — | — | — | — | 266.1K | 0.00% | ↗ |
| 64 | 2007 | Stephen R. Seiler Former President and CEO | 350.0K | — | — | 270.0K | — | 14.8K | 634.8K | 42.53% | ↗ |
| 65 | 2007 | David P. Nowotnik, Ph.D. Senior Vice President Research | 253.6K | — | — | — | — | 12.2K | 265.8K | 0.00% | ↗ |
| 66 | 2007 | Phillip S. Wise Vice President, Business | 200.0K | — | — | — | — | 9.9K | 209.9K | 0.00% | ↗ |
| 67 | 2007 | Stephen B. Thompson Vice President, Chief Financial Officer | 154.1K | — | — | — | — | 7.4K | 161.5K | 0.00% | ↗ |
| 68 | 2005 | David P. Nowotnik, Ph.D. Senior Vice President Research and Development | 250.7K | 25.4K | — | — | — | 7.1K | 283.2K | 0.00% | ↗ |
| 69 | 2005 | Rosemary Mazanet | 217.5K | 30.0K | — | 280.0K | — | 1.3K | 248.8K | 112.54% | ↗ |
| 70 | 2005 | Stephen B. Thompson Vice President, Chief | 152.3K | 15.4K | — | — | — | 4.5K | 172.2K | 0.00% | ↗ |
| 71 | 2005 | Kerry P. Gray Former President and CEO | 133.3K | — | — | — | — | 3.5K | 136.8K | 0.00% | ↗ |
| 72 | 2005 | Kerry P. Gray Former President and CEO Phillip S. Wise Vice President, Business Development | 133.3K | — | — | — | — | 3.5K | 136.8K | 0.00% | ↗ |
| 73 | 2004 | Kerry P. Gray Former President and CEO | 384.4K | — | — | 100.0K | — | 11.5K | 395.9K | 25.26% | ↗ |
| 74 | 2004 | David P. Nowotnik, Ph.D. Senior Vice President Research and Development | 239.0K | — | — | — | — | 6.4K | 245.4K | 0.00% | ↗ |
| 75 | 2004 | Stephen B. Thompson Vice President, Chief | 145.3K | — | — | — | — | 3.4K | 148.6K | 0.00% | ↗ |
| 76 | 2003 | Kerry P. Gray Former President and CEO | 366.8K | 130.0K | — | — | — | 10.8K | 507.7K | 0.00% | ↗ |
| 77 | 2003 | David P. Nowotnik, Ph.D. Senior Vice President Research and Development | 226.5K | 24.2K | — | — | — | 6.0K | 256.7K | 0.00% | ↗ |
| 78 | 2003 | Stephen B. Thompson Vice President, Chief | 138.0K | 14.7K | — | — | — | 3.9K | 156.7K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Vishwas Seshadri | President, Chief Executive Officer & Director | 2M | — |
| Joseph Walter Vazzano | Chief Financial Officer | 898.5K | male |
| Brendan O'Malley | Chief Legal Officer | 783.9K | — |
| Gianine Esposito | Senior VP & Chief People Officer | — | female |
| Gregory Gin | Vice President of Investor Relations & Corporation Communications | — | male |
| Alison Hardgrove | Chief People Officer | — | female |
| Jon Voss | Vice President & Head of Quality | — | male |
| Madhav Vasanthavada | Chief Commercial Officer | — | — |
| Megan Callan | Vice President & Head of Quality | — | female |
| Mohamad Tabrizi | Chief Business Officer | — | male |
| James A. Gow | SVP, Head of Clinical Development & Medical Affairs | — | — |
| Brian Kevany | Chief Technical & Scientific Officer | — | male |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ABEO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
